Fourth Quarter 2023 Financial Results: Revenue of $1,035 million Reported Net Loss of $141 million, Adjusted Net Income of $39 million Adjusted EBITDA of $165 million or 15.9% of Revenue Reported EPS of $(0.29), Adjusted EPS of $0.08 Net leverage ratio of 5.6x Adjusted EBITDA Full Year…
Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
This post was originally published on this site